Altair Engineering diskutieren
Altair Engineering
WKN: A2DYPC / Symbol: ALTR / Name: Altair Engineering / Aktie / Small Cap /
87,00 €
2,35 %
Altair Engineering Inc. (NASDAQ: ALTR) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $39.00 to $44.00. They now have a "sell" rating on the stock.
Ratings data for ALTR provided by MarketBeat
Altair Engineering Inc. (NASDAQ: ALTR) had its price target raised by analysts at Rosenblatt Securities from $70.00 to $74.00. They now have a "buy" rating on the stock.
Ratings data for ALTR provided by MarketBeat
Altair Engineering Inc. (NASDAQ: ALTR) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $77.00 price target on the stock.
Ratings data for ALTR provided by MarketBeat
Altair Engineering Inc. (NASDAQ: ALTR) had its "buy" rating re-affirmed by analysts at Rosenblatt Securities. They now have a $74.00 price target on the stock.
Ratings data for ALTR provided by MarketBeat
Altair Engineering Inc. (NASDAQ: ALTR) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $86.00 price target on the stock.
Ratings data for ALTR provided by MarketBeat
Altair Engineering Inc. (NASDAQ: ALTR) had its price target raised by analysts at Oppenheimer Holdings Inc. from $95.00 to $100.00. They now have an "outperform" rating on the stock.
Ratings data for ALTR provided by MarketBeat
Altair Engineering Inc. (NASDAQ: ALTR) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $100.00 price target on the stock.
Ratings data for ALTR provided by MarketBeat
Altair Engineering Inc. (NASDAQ: ALTR) had its price target raised by analysts at JPMorgan Chase & Co. from $86.00 to $95.00. They now have an "overweight" rating on the stock.
Ratings data for ALTR provided by MarketBeat
Altair Engineering Inc. (NASDAQ: ALTR) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $100.00 price target on the stock.
Ratings data for ALTR provided by MarketBeat
Neueste Beiträge
StockNews_com in Ampio Pharmaceuticals Inc. diskutieren